Skip to main content
eLife logoLink to eLife
. 2024 Nov 6;13:RP96755. doi: 10.7554/eLife.96755

DNAH3 deficiency causes flagellar inner dynein arm loss and male infertility in humans and mice

Xiang Wang 1,2,, Gan Shen 1,, Yihong Yang 3,, Chuan Jiang 1,, Tiechao Ruan 4,, Xue Yang 1, Liangchai Zhuo 1, Yingteng Zhang 1, Yangdi Ou 5, Xinya Zhao 6, Shunhua Long 7,8, Xiangrong Tang 7,8, Tingting Lin 7,8,, Ying Shen 1,2,
Editors: Izuchukwu Okafor9, Wei Yan10
PMCID: PMC11540302  PMID: 39503742

Abstract

Axonemal protein complexes, including the outer and inner dynein arms (ODA/IDA), are highly ordered structures of the sperm flagella that drive sperm motility. Deficiencies in several axonemal proteins have been associated with male infertility, which is characterized by asthenozoospermia or asthenoteratozoospermia. Dynein axonemal heavy chain 3 (DNAH3) resides in the IDA and is highly expressed in the testis. However, the relationship between DNAH3 and male infertility is still unclear. Herein, we identified biallelic variants of DNAH3 in four unrelated Han Chinese infertile men with asthenoteratozoospermia through whole-exome sequencing (WES). These variants contributed to deficient DNAH3 expression in the patients’ sperm flagella. Importantly, the patients represented the anomalous sperm flagellar morphology, and the flagellar ultrastructure was severely disrupted. Intriguingly, Dnah3 knockout (KO) male mice were also infertile, especially showing the severe reduction in sperm movement with the abnormal IDA and mitochondrion structure. Mechanically, nonfunctional DNAH3 expression resulted in decreased expression of IDA-associated proteins in the spermatozoa flagella of patients and KO mice, including DNAH1, DNAH6, and DNALI1, the deletion of which has been involved in disruption of sperm motility. Moreover, the infertility of patients with DNAH3 variants and Dnah3 KO mice could be rescued by intracytoplasmic sperm injection (ICSI) treatment. Our findings indicated that DNAH3 is a novel pathogenic gene for asthenoteratozoospermia and may further contribute to the diagnosis, genetic counseling, and prognosis of male infertility.

Research organism: Human, Mouse

Introduction

Infertility is a global public health and social problem that affects approximately one in six couples worldwide (Cox et al., 2022). Male infertility, which accounts for half of infertile cases, is a multifactorial disease with common phenotypes, including oligo/azoospermia (poor sperm count or absence of spermatozoa); teratozoospermia (aberrant sperm morphology); asthenozoospermia (weakened sperm motility); and a combination of these phenotypes, such as asthenoteratozoospermia, oligoasthenozoospermia, oligoteratozoospermia, and oligoasthenoteratozoospermia (Eisenberg et al., 2023; Agarwal et al., 2015).

Asthenoteratozoospermia is one of the most common phenotypes of male infertility, and genetic factors have been established as the predominant cause of asthenoteratozoospermia. Multiple morphological abnormalities of the flagella (MMAF), a subtype of asthenoteratozoospermia, characterized by a mosaic of abnormalities of the flagellar morphology, including absent, short, coiled, bent and/or irregular flagella, is almost always caused by genetic defects (Touré et al., 2021; Wang et al., 2020). To date, more than 40 genes have been identified as pathogenic genes of MMAF, but these genes can only explain approximately 60% of MMAF-affected cases (Wang et al., 2022; Lu et al., 2021; Houston et al., 2021; Jiao et al., 2021). Therefore, the genetic basis of the remaining cases is still unknown.

The motility of a sperm is driven by its rhythmically beating flagella, and at the center of the flagella lies a conserved axonemal structure, containing the ‘9+2’ microtubular arrangement: a ring of nine microtubule doublets (MTDs) surrounding a central pair (CP) of singlet microtubules. Each MTD consists of an A tubule and a B tubule, and the outer (ODA) and inner (IDA) dynein arms are anchored along the A tubule (Leung et al., 2023). The ODA and IDA are ATPase-based protein complexes that drive the movement between the A tubule and the neighboring B tubule of the next doublet, producing the original force for sperm motility (Burgess et al., 2003; Linck et al., 2016). Structural and functional abnormalities of the ODA and IDA have been demonstrated to cause male infertility associated with asthenozoospermia and/or asthenoteratozoospermia (Touré et al., 2021; Gunes et al., 2020; Sironen et al., 2020).

The dynein axonemal heavy chain (DNAH) family comprises a series of proteins (DNAH1–3, DNAH5–12, and DNAH17) that are precisely assembled with other axonemal dynein motor proteins in the ODAs and IDAs of sperm flagella and motile cilia (King, 2016; Walton et al., 2023; Aprea et al., 2021). In humans, DNAH1, DNAH2, DNAH6, DNAH7, DNAH8, DNAH10, DNAH12, and DNAH17 are highly expressed in the testis, and deficiency of these proteins has been demonstrated to cause MMAF-associated asthenoteratozoospermia (Ben Khelifa et al., 2014; Hwang et al., 2021; Tu et al., 2019; Gao et al., 2022; Liu et al., 2020; Tu et al., 2021; Li et al., 2021; Whitfield et al., 2019). DNAH3 is an evolutionarily conserved IDA-associated protein and is highly expressed in testes of humans and mice (Chapelin et al., 1997). Deficient DNAH3 has been shown to impair sperm motility in Drosophila and cattle (Karak et al., 2015; Modiba et al., 2022). In humans, DNAH3 has been identified as a novel breast cancer candidate gene (Hamdi et al., 2018). However, the role of DNAH3 in male reproduction in humans and mice remains largely unknown.

In the present study, we identified four biallelic variations in DNAH3 in four unrelated Han Chinese patients with asthenoteratozoospermia using whole-exome sequencing (WES). The spermatozoa of the patients showed extremely reduced sperm motility and a high proportion of sperm tail defects characterized by the MMAF phenotype. We further generated Dnah3 knockout (KO) mice, and the male KO mice expectedly showed aberrations in sperm movement, flagellar IDA, and mitochondrion. Moreover, the absence of DNAH3 led to decreased expression of other IDA-associated proteins, including DNAH1, DNAH6 and DNALI1. Importantly, good outcomes of intracytoplasmic sperm injection (ICSI) treatment were observed in DNAH3-deficient patients and Dnah3 KO mice. This study revealed DNAH3 as a novel pathogenic gene of asthenoteratozoospermia, and the findings provide valuable suggestions for the clinical diagnosis and treatment of male infertility.

Results

Identification of biallelic pathogenic variants of DNAH3 in four unrelated infertile men

In the present study, we employed whole-exome sequencing (WES) to identify potential candidate variants associated with primary asthenoteratozoospermia. After comprehensive filtering and screening, we identified 98, 101, 67, and 91 candidate variants for Patient 1, Patient 2, Patient 3, and Patient 4, respectively (Figure 1—source data 1). To refine these candidate variants, we excluded those whose corresponding genes were not expressed in the human or mouse testis, were associated with diseases unrelated to male infertility, or were monoallelic variants. Ultimately, only bi-allelic variants in DNAH3 (NG_052617.1, NM_017539.2, NP_060009.1) remained, suggesting as the pathogenic variants responsible for the infertility of the patients: a compound heterozygous mutation of c.3590C>T (p.Pro1197Leu) and c.3590C>G (p.Pro1197Arg) in Patient 1, a homozygous missense mutation of c.4837G>T (p.Ala1613Ser) in Patient 2, a compound heterozygous mutation of c.5587del (p.Leu1863*) and c.10355C>T (p.Ser3452Leu) in Patient 3, and a compound heterozygous mutation of c.2314C>T (p.Arg772Trp) and c.4045G>A (p.Asp1349Asn) in Patient 4 (Figure 1A). Importantly, routine semen analysis revealed that all patients showed extremely reduced sperm motility and a high proportion of sperm tail defects (Table 1). These variants either were not recorded or had an extremely low frequency in East Asian population in multiple public population databases, including the ExAC browser, GnomAD and the 1000 Genomes Project, and were predicted to be potentially deleterious by SIFT (https://sift.bii.a-star.edu.sg/), PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/), MutationTaster (https://www.mutationtaster.org/), and CADD (https://cadd.gs.washington.edu/; Table 2; Ng and Henikoff, 2003; Adzhubei et al., 2010; Schwarz et al., 2014; Rentzsch et al., 2019). Next, Sanger sequencing confirmed these variants in the probands, and their fertile parents carried the heterozygous variants (Figure 1A). Moreover, the variant sites are localized in several domains of the DNAH3 protein and are highly conserved across species (Figure 1B).

Figure 1. Identification of biallelic pathogenic variants in DNAH3 from four unrelated infertile families.

Figure 1.

(A) Pedigrees of four families affected by DNAH3 variants (M1–M7). Black arrows indicate the probands in these families. (B) Location of the variants and conservation of affected amino acids in DNAH3. Black arrows indicate the position of the variants. (C) Immunofluorescence staining of DNAH3 in sperm from the patients and normal control. Red, DNAH3; green, α-Tubulin; blue, DAPI; scale bars, 5 μm. (D) Western blotting analysis of DNAH3 expressed in spermatozoa from the patients and normal control.

Figure 1—source data 1. Summary of whole exome sequencing and the candidate variants identified.
Figure 1—source data 2. Primers for Sanger sequencing.
Figure 1—source data 3. PDF file containing original western blotting for Figure 1D.
Figure 1—source data 4. Original files for western blotting analysis displayed in Figure 1D.

Table 1. Semen analysis of the patients in the present study.

Patient 1 Patient 2 Patient 3 Patient 4 Reference
Semen parameters Semen volume (ml) 4.3 3.3 0.8 4.6 ≥1.5
Semen concentration (106 /ml) 2.0 0.5 11.0 21.0 ≥15.0
Motility (%) 6.0 3.0 0 0 ≥40.0
Progressive motility (%) 0 2.3 0 0 ≥32.0
Sperm morphology Normal (%) 1.3 1.1 1.8 1.2 ≥4.0
Tail defects (%) 91.3 87.5 96.5 97.5 -

-,not applicable.

Table 2. Variants analysis of the patients in the present study.

Patient 1 Patient 2 Patient 3 Patient 4
Variant cDNA mutation * c.3590C>T c.3590C>G c.4837G>T c.5587del c.10355C>T c.2314C>T c.4045G>A
Protein alteration p.Pro1197Leu p.Pro1197Arg p.Ala1613Ser p.Leu1863* p.Ser3452Leu p.Arg772Trp p.Asp1349Asn
Mutation type Missense Missense Missense Nonsense Missense Missense Missense
Allele frequency ExAC_EAS 0.0001 0 0.004165 0 0.0006 0.0019 0.0065
GnomAD_EAS 0.00005016 0 0.00277415 0 0.0008 0.002 0.007
1000 Genomes Project_EAS 0 0 0.0050 0 0 0.0040 0.0069
Function prediction SIFT Deleterious Deleterious Deleterious / Tolerated Deleterious Deleterious
Polyphen-2 Probably damaging Probably damaging Probably damaging / Probably damaging Probably damaging Probably damaging
Mutation Taster Disease causing Disease causing Disease causing / Disease causing Disease causing Disease causing
CADD 33 29.5 27.5 / 25.4 27.9 34

/,not applicable.

score >4.0 is predicted to be damaging.

Strikingly, immunofluorescence staining revealed that DNAH3 was exclusively resided in the tail and concentrated in the midpiece of control sperm. However, the fluorescence signal of DNAH3 was hardly detected in the patients’ spermatozoa (Figure 1C). Additionally, subsequent western blotting analysis yielded consistent results with immunofluorescence staining, indicating that these variants led to disrupted expression of DNAH3 (Figure 1D). These results suggested that biallelic variants in DNAH3 disrupted DNAH3 expression and might be responsible for the infertility of the four patients.

Asthenoteratozoospermia phenotype is observed in patients with DNAH3 variants

We next investigated the aberrant sperm morphology of the patients using Papanicolaou staining and SEM analysis. Notably, the tails of sperm from the patients exhibited a typical phenotype associated with MMAF, including coiled, short, bent, irregular, and/or absent flagella (Figure 2A and B, Figure 2—figure supplement 1). In addition, a fraction of defects in the sperm head were also present in the patients’ sperm (Figure 2B).

Figure 2. Defects in sperm morphology of the patients harboring DNAH3 variants.

(A, B) Abnormal sperm morphology was observed through Papanicolaou staining (A), and SEM analysis (B) compared to normal control. Scale bars, 5 μm.

Figure 2.

Figure 2—figure supplement 1. The histogram of various flagellar morphology in the normal control and patients.

Figure 2—figure supplement 1.

Figure 2—figure supplement 1—source data 1. The percentage distribution of various flagellar morphology in the normal control and patients.

TEM was employed to determine the ultrastructure of the sperm from the patients. Compared to the integrated and well-organized ‘9 + 2’ axonemal arrangement of the sperm flagella from the normal control, spermatozoa from the patients showed absent or disordered CPs, MTDs, and outer dense fibers (ODFs) in different regions of the flagella (Figure 3A, Figure 3—figure supplement 1). Interestingly, the IDAs of sperm flagella of the patients were hardly captured compared to the control (Figure 3A). Additionally, in the midpiece of sperm flagella of the patients, dissolved mitochondrial material was also observed evidently under TEM (Figure 3A). We next conducted immunofluorescence staining to label the mitochondria of patients’ sperm with TOM20, a subunit of the mitochondrial import receptor. Remarkably, in contrast to the robust TOM20 signals observed in the normal control, the TOM20 signals in the sperm from the patients were considerably diminished, indicating a disrupted mitochondrial function (Figure 3B). Together, these data suggested that DNAH3 may function in sperm flagellar development, and loss-of-function variants were associated with MMAF in humans.

Figure 3. Ultrastructural and mitochondrial defects in sperm from infertile men with DNAH3 variants.

(A) TEM analysis of sperm obtained from a normal control and patients harboring DNAH3 variants. Cross-sections of the midpiece, principal piece and endpiece of sperm from normal control showed the typical ‘‘9+2’’ microtubule structure, and an IDA and an ODA were displayed on the A-tube of each microtubule doublet. Cross-sections of the midpiece, principal piece and endpiece of sperm from the patients displayed absent or disordered CPs, MTDs and ODFs, as well as an evident missing of the IDAs in different pieces of the flagella. M, mitochondria sheath; ODF, outer dense fiber; MTD, microtubule doublets; CP, central pair; IDA, inner dynein arms; ODA, outer dynein arms. Scale bars, 200 nm. (B) Immunofluorescence staining of TOM20 in sperm from the patients and normal control. Red, TOM20; green, α-Tubulin; blue, DAPI; scale bars, 5 μm.

Figure 3.

Figure 3—figure supplement 1. The percentage of aberrant ultrastructure in different cross-sections of sperm from the normal control and patients.

Figure 3—figure supplement 1.

DNAH3 is exclusively expressed in the sperm flagella of humans and mice

To further understand the function of DNAH3 in male reproduction, we explored the expression pattern of DNAH3 in humans and mice. qPCR results revealed that Dnah3 was predominantly expressed in the mouse testis (Figure 4—figure supplement 1A). Moreover, when observing the expression of Dnah3 in testes from mice at different postnatal days, we found that Dnah3 expression was significantly elevated beginning on postnatal Day 22, peaked at postnatal Day 30, and maintained a stable expression level thereafter (Figure 4—figure supplement 1B). In addition, germ cells at different stages were isolated from the testes of humans and mice and were stained with anti-DNAH3 antibody. The results showed that DNAH3 was expressed in the cytoplasm of spermatocytes and spermatogonia and then obviously in the flagellum of early and late spermatids (Figure 4—figure supplement 2A, B). These expression data suggest that DNAH3 may play an important role in sperm flagellar development during spermatogenesis in humans and mice.

Deletion of Dnah3 causes male infertility in mice

Considering the absent expression of DNAH3 in the patient sperm, we generated Dnah3 KO mice using CRISPR‒Cas9 technology to further confirm the essential role of DNAH3 in spermatogenesis (Figure 4—figure supplement 3A). PCR, qPCR, and immunofluorescence staining were used to confirm that Dnah3 was null in KO mice (Figure 4—figure supplement 3B–E). The Dnah3 KO mice survived without any evident abnormalities in development and behavior. H&E staining further revealed that there were no histological differences in the lung, brain, eye, or oviduct between wild-type (WT) and Dnah3 KO mice (Figure 4—figure supplement 4A). In addition, no obvious abnormalities in ciliary development were observed in these organs in KO mice compared to WT mice (Figure 4—figure supplement 4B). The Dnah3 KO female mice were fertile with normal oocyte development (Figure 4—figure supplement 5A). However, the Dnah3 KO male mice were completely infertile (Figure 4A). We next examined the testis and epididymis of Dnah3 KO male mice to elucidate the etiology of infertility. There was no detectable difference in the testis/body weight ratio of Dnah3 KO mice when compared to WT mice (Figure 4—figure supplement 5B).

Figure 4. Dnah3 KO male mice are infertile.

(A) Fertility of Dnah3 KO mice. The KO male mice were infertile (n=five biologically independent WT mice or KO mice; Student’s t test; *, p<0.05; NS, no significance; error bars, s.e.m.). (B) TEM analysis of the cross-sections of spermatozoa from Dnah3 KO mice revealed an obvious absence of IDAs in different pieces of the flagella compared to WT mice. M, mitochondrion sheath; ODF, outer dense fiber; MTD, microtubule doublet; CP, central pair; IDA, inner dynein arm; ODA, outer dynein arm. Scale bars, 200 nm. (C) Disrupted mitochondria were observed in spermatozoa tail from Dnah3 KO mice by TEM analysis. The yellow arrows indicate the normal mitochondria. The red arrowheads indicate the dilated intermembrane spaces and dissolved mitochondrial material. M, mitochondrion sheath. Scale bars, 200 nm. (D) Immunofluorescence staining of SLC25A4 indicated impaired mitochondrial formation in Dnah3 KO mice compared to WT mice. Red, SLC25A4; green, α-Tubulin; blue, DAPI; scale bars, 5 µm.

Figure 4.

Figure 4—figure supplement 1. The expression of DNAH3 in mouse testis.

Figure 4—figure supplement 1.

(A) qPCR analysis revealed that Dnah3 was highly expressed in the mouse testis. (B) qPCR analysis showed that Dnah3 expression was significantly elevated beginning on postnatal Day 12, peaked at postnatal Day 30, and maintained a stable expression level thereafter.
Figure 4—figure supplement 1—source data 1. PDF file containing original gels for Figure 4—figure supplement 1A, B.
Figure 4—figure supplement 1—source data 2. Original files for gel analysis displayed in Figure 4—figure supplement 1A, B.
Figure 4—figure supplement 2. DNAH3 is expressed during spermatogenesis in mice and humans.

Figure 4—figure supplement 2.

(A) Immunofluorescence staining of DNAH3 in isolated mouse germ cells. Pink, PNA; green, DNAH3; blue, DAPI; scale bars, 5 μm. (B) Immunofluorescence staining of DNAH3 in isolated human germ cells. Pink, PNA; green, DNAH3; blue, DAPI; scale bars, 5 μm.
Figure 4—figure supplement 3. Generation of Dnah3 KO mice.

Figure 4—figure supplement 3.

(A) Schematic illustration of the strategy for the generation of Dnah3 KO mice. (B, C) PCR sequencing (B) and qPCR (C) were used to confirm the genotype and KO efficiency (n=three biologically independent WT mice or KO mice; Student’s t test; *, p<0.05; error bars, s.e.m.). (D) Immunofluorescence staining of DNAH3 in testis of Dnah3 KO mice and WT mice. Green, DNAH3; blue, DAPI; scale bars, 75 μm. (E) Immunofluorescence staining of DNAH3 in spermatozoa isolated from the cauda epididymis of Dnah3 KO mice and WT mice. Red, DNAH3; green, α-Tubulin; blue, DAPI; scale bars, 5 μm.
Figure 4—figure supplement 3—source data 1. Primers for Sanger sequencing and qPCR.
Figure 4—figure supplement 4. Ciliary development of Dnah3 KO mice.

Figure 4—figure supplement 4.

(A) H&E staining of lung, brain, eye, and oviduct from Dnah3 KO mice and WT mice. Scale bars, 100 μm. (B) Analysis of ciliary development in the lung, brain, eye, and oviduct from Dnah3 KO mice and WT mice by using immunofluorescence staining. Green, Ac-Tubulin; blue, DAPI; scale bars, 20 μm.
Figure 4—figure supplement 5. Fertility of Dnah3 KO mice.

Figure 4—figure supplement 5.

(A) H&E staining of ovary tissue sections from 8-week-old Dnah3 KO female mice and WT female mice. Scale bars, 75 μm (n=three biologically independent WT mice or KO mice). (B) Sizes of the testis and epididymis of the 8-week-old Dnah3 KO and WT mice (n=three biologically independent WT mice or KO mice; Student’s t test; NS, no significance; error bars, s.e.m.).
Figure 4—figure supplement 6. Morphology and ultrastructure of sperm isolated from Dnah3 KO mice.

Figure 4—figure supplement 6.

(A, B) Papanicolaou staining (A), and SEM analysis (B) revealed morphological defects in partial spermatozoa from Dnah3 KO mice compared to WT mice. Scale bars in (A), 5 μm; scale bars in (B), 2.5 μm. (n=three biologically independent WT mice or KO mice; Student’s t test; error bars, s.e.m.). (C) The percentage of aberrant axonemal arrangement in different cross-sections of sperm from WT mice and Dnah3 KO mice. (n=three biologically independent WT mice or KO mice; error bars, s.e.m.). (D) The percentage of microtubule doublets that presented IDAs in WT mice and Dnah3 KO mice. (n=three biologically independent WT mice or KO mice; Student’s t test; error bars, s.e.m.). (E) Statistics of malformed mitochondria in the midpiece of sperm from WT mice and Dnah3 KO mice. (n=three biologically independent WT mice or KO mice; Student’s t test; error bars, s.e.m.).
Figure 4—video 1. CASA of sperm from WT mice.
Download video file (5.7MB, mp4)
Sperm from the epididymis of WT mice were collected, incubated, and recorded under a phase-contrast microscope. A normal quantity and motility of sperm were observed in the WT mice (n=three biologically independent WT mice).
Figure 4—video 2. CASA of sperm from Dnah3 KO mice.
Download video file (3.6MB, mp4)
Epididymal sperm of Dnah3 KO mice were collected, incubated in HTF medium at 37 °C for 10 min, and recorded under a phase-contrast microscope. The movie showed a significantly reduced motility of sperm from Dnah3 KO (n=three biologically independent Dnah3 mice).

Moreover, subsequent computer-assisted sperm analysis (CASA) also showed that sperm isolated from the cauda epididymis were slightly decreased, and nearly all sperm were completely immobile (Table 3, Figure 4—video 1 and Figure 4—video 2). Papanicolaou staining and SEM analysis revealed morphological defects in partial spermatozoa from Dnah3 KO mice, including coiled, bent, and irregular flagella, as well as aberrant heads and acephalic spermatozoa (Figure 4—figure supplement 6A, B).

Table 3. Semen analysis using CASA in the Dnah3 KO mice.

WT KO p* value
Semen parameters
Sperm concentration (106/ml) 112.32±18.26 105.17±11.15 0.059
Motility (%) * 71.56±3.97 4.37±1.15 <0.01
Progressive motility (%) * 60.36±4.32 4.37±1.15 <0.01
Sperm locomotion parameters
Curvilinear velocity (VCL) (μm/s)* 67.54±6.79 9.07±1.22 <0.01
Straight-line velocity (VSL) (μm/s)* 28.91±4.86 2.68±0.52 <0.01
Average path velocity (VAP) (μm/s)* 39.02±5.31 3.85±0.82 <0.01
Amplitude of lateral head displacement (ALH) (μm)* 0.71±0.03 0.13±0.04 <0.01
Linearity (LIN)* 0.43±0.07 0.30±0.02 0.037
Wobble (WOB,=VAP/VCL)* 0.58±0.06 0.42±0.05 0.024
Straightness (STR,=VSL/VAP) 0.74±0.22 0.70±0.13 0.80
Beat-cross frequency (BCF) (Hz)* 4.86±0.12 0.73±0.08 <0.01
*

A significant difference, two-sided student’s t-test. n=3 biologically independent WT mice or KO mice.

Epididymides and vas deferens.

TEM was further utilized to evaluate the sperm flagellar ultrastructure of Dnah3 KO mice. There were no obvious abnormalities of ‘9+2’ microtube arrangement in most sperm from the Dnah3 KO mice when compared to WT mice (Figure 4B, Figure 4—figure supplement 6C). However, in contrast to the clear display of an IDA and an ODA on the A-tube of each microtubule doublet in the sperm flagella of WT mice, the sperm flagella of Dnah3 KO mice exhibited an absence of almost all the IDAs (Figure 4B, Figure 4—figure supplement 6D). In addition, the disrupted mitochondria of spermatozoa from Dnah3 KO mice were also observed under TEM, as manifested by the dilated intermembrane spaces and dissolved mitochondrial material (Figure 4B and C, Figure 4—figure supplement 6E). We next performed immunofluorescence staining to label SLC25A4, which is responsible for the exchange of ATP and ADP across the mitochondrial inner membrane. Strikingly, compared to the bright fluorescence signals in the midpiece of WT sperm, the signals Dnah3 KO were significantly diminished (Figure 4D), indicating impaired mitochondrial function. Collectively, DNAH3 is essential for spermatogenesis, and its deficiency seriously damages the sperm motility and IDAs in both humans and mice.

DNAH3 deficiency impairs IDAs related to the reduction of IDA-associated proteins

Considering the disrupted IDAs revealed by TEM analysis in both our patients and Dnah3 KO mice, we speculated whether the defective IDAs were attributed to the decreased expression of the key IDA-associated proteins. The immunofluorescence data showed that DNAH1/DNAH6 and DNALI1, corresponding to the heavy and light intermediate chains of the IDAs (Walton et al., 2023), respectively, were almost invisible along the sperm flagella of the patients when compared to control (Figure 5A–C). Consistent results were obtained in our subsequent western blotting analysis of sperm lysates from the patients (Figure 5D–F), indicating that DNAH3 may manipulate the assembly of IDA through regulating the expression of IDA-associated proteins. In contrast, DNAH8/DNAH17 and DNAI1, corresponding to the heavy and intermediate chains of ODAs (Whitfield et al., 2019), were readily detectable in the patients’ sperm flagella and were comparable to the control (Figure 5—figure supplement 1A–C), suggesting that DNAH3 may not regulate the expression of ODA-associated proteins. We also performed immunofluorescence staining and western blotting analysis of DNAH1, DNAH6, DNALI1, DNAH8, DNAH17 and DNAI1 on sperm from Dnah3 KO mice, and the results observed were consistent with those of the patients (Figure 6A–F, Figure 6—figure supplement 1A–C). These findings suggested that other IDA-associated proteins might be downstream effectors of DNAH3, which needs more future research.

Figure 5. Immunofluorescence staining and western blotting analysis of IDA-associated proteins in spermatozoa obtained from normal control and patients with DNAH3 variants.

(A – C) Immunofluorescence staining of DNAH1 (A), DNAH6 (B) and DNALI1 (C) in spermatozoa from patients and normal controls. Red, DNAH1 in (A), DNAH6 in (B), DNALI1 in (C); green, α-Tubulin; blue, DAPI; scale bars, 5 μm. (D – F) Western blotting analysis of DNAH1(D), DNAH6 (E), DNALI1 (F) in sperm lysates from the patients and normal control.

Figure 5—source data 1. PDF file containing original western blotting for Figure 5D–F and Figure 6D–F.
Figure 5—source data 2. Original files for western blotting analysis displayed in Figure 5D–F and Figure 6D–F.

Figure 5.

Figure 5—figure supplement 1. Immunofluorescence staining of ODA-associated proteins in spermatozoa obtained from variants within DNAH3 patients.

Figure 5—figure supplement 1.

(A – C) The expression of DNAH8 (A), DNAH17 (B) and DNAI1 (C) in spermatozoa of the patients was comparable to that in normal controls. Red, DNAH8 in (A), DNAH17 in (B), DNAI1 in (C); green, α-Tubulin; blue, DAPI; scale bars, 5 μm.

Figure 6. Immunofluorescence staining and western blotting analysis of IDA-associated proteins in spermatozoa from WT and Dnah3 KO mice.

(A – C) Immunofluorescence staining of DNAH1 (A), DNAH6 (B) and DNALI1 (C) in spermatozoa from Dnah3 KO and WT mice. Red, DNAH1 in (A), DNAH6 in (B), DNALI1 in (C); green, α-Tubulin; blue, DAPI; scale bars, 5 μm. (D – F) Western blotting analysis of DNAH1(D), DNAH6 (E) and DNALI1 (F) in spermatozoa lysates from Dnah3 KO and WT mice.

Figure 6.

Figure 6—figure supplement 1. Immunofluorescence staining of ODA-associated proteins in spermatozoa of Dnah3 KO and WT mice.

Figure 6—figure supplement 1.

(A – C) The expression of DNAH8 (A), DNAH17 (B) and DNAI1 (C) in spermatozoa from Dnah3 KO mice was comparable to that in spermatozoa from WT mice. Red, DNAH8 in (A), DNAH17 in (B), DNAI1 in (C); green, α-Tubulin; blue, DAPI; scale bars, 5 μm.

ICSI treatment of humans with DNAH3 variants and Dnah3 KO mice

ICSI treatment has been reported to be effective in asthenoteratozoospermia-associated infertility (Tsai et al., 2011; Colpi et al., 2018). ICSI cycles were attempted for the patients after written informed consent was obtained. The female partners all had normal basal hormone levels and underwent a long gonadotrophin-releasing hormone agonist protocol (Table 4). The wife of Patient 1 underwent one ICSI attempt. A total of 21 metaphase II (MII) oocytes were retrieved and microinjected, of which 17 oocytes were successfully fertilized (17/21, 80.95%) and cleaved (17/17, 100%). Thirteen Day 3 (D3) embryos were formed, six of which developed into blastocysts (8/13, 61.54%) after standard embryo culture. Two blastocysts were transferred, one of which was implanted. She eventually achieved clinical pregnancy, and the pregnancy is ongoing (Table 4). The partner of Patient 2 underwent two ICSI attempts. In her first ICSI attempt, six MII oocytes were retrieved, of which three were fertilized (3/6, 50%) and cleaved (3/3, 100%). After standard embryo culture, two D3 embryos were formed and transferred. However, this ICSI failed because no embryos were implanted. In her second ICSI attempt, all five MII oocytes were fertilized and cleaved (5/5, 100%). Five D3 embryos were obtained, of which two were transferred, but no embryos were implanted. The remaining three D3 embryos were cultured continuously, and two available blastocysts were formed and kept to be transferred in the future (Table 4). The partner of Patient 3 underwent one ICSI attempt. Of the 20 MII oocytes retrieved, 19 oocytes were fertilized (19/20, 95.0%) and cleaved (19/19, 100%). Fifteen D3 embryos were obtained, and 10 developed into available blastocysts (10/15, 66.7%). One blastocyst was transferred and implanted. She achieved clinical pregnancy, and the pregnancy is ongoing (Table 4). The wife of Patient 4 underwent four failed ICSI attempts. In her first two ICSI attempts, 13 and 12 MII oocytes were retrieved, of which five (5/12, 41.67%) and six (6/13, 46.15%), respectively, were fertilized and cleaved. Two available D3 embryos were obtained and transferred in both ICSI attempts, but no embryos were implanted. In her third ICSI attempt, of the eight MII oocytes retrieved, four (4/8, 50%) were fertilized and cleaved (4/4, 100%). However, no available D3 embryos were acquired. In her last ICSI attempt, seven MII oocytes were retrieved, of which three were fertilized (3/7, 42.68%) and two were cleaved (2/3, 66.7%), but no available D3 embryos were formed (Table 4). The vivid embryonic development of the partner of Patient 1 and Patient 3 after ICSI treatment was shown in Figure 7A.

Table 4. Outcomes of ICSI treatment in the patients with DNAH3 mutations.

Subjects Patient Patient 1 Patient 2 Patient 3 Patient 4
Female age (y) 24 30 30 36
Length of primary infertility history (y) 6 1 3 8
Basal hormones FSH (IU/L) 7.1 8.5 3.49 4.3
LH (IU/L) 4.44 2.5 4.2 2.6
E2 (pg/mL) 83 50 43.49 68
Prog (ng/mL) 0.2 0.6 0.3 0.3
ICSI Cycles Cycle 1 Cycle 1 Cycle 2 Cycle 1 Cycle 1 Cycle 2 Cycle 3 Cycle 4
E2 level on the trigger day (pg/ml) 3366 1519.6 1582.4 >5,000 4440 5000 3152 2206
No. of follicles ≥14 mm on the trigger day 15 6 5 20 13 12 14 11
No. of follicles ≥18 mm on the trigger day 10 3 4 8 11 9 7 5
No. of oocytes retrieved 24 6 5 25 16 20 21 14
ICSI progress No. of MII oocytes 21 6 5 20 12 13 8 7
Fertilization rate (%) 80.95 (17/21) 50 (3/6) 100 (5/5) 95 (19/20) 41.67 (5/12) 46.15 (6/13) 50 (4/8) 42.86 (3/7)
Cleavage Rate (%) 100 (17/17) 100 (2/2) 100 (5/5) 100 (19/19) 100 (5/5) 100 (6/6) 100 (4/4) 66.7 (2/3)
Available D3 embryos 13 2 5 15 2 2 0 0
Blastocyst formation rate (%) 61.5 (8/13) 0 66.7 (2/3) 66.7 (10/15) - - - -
Clinical outcomes No. of embryos transferred 2 blastocysts 0 2 D3 1 blastocyst 2 D3 2 D3 - -
Implantation rate (%) 50 (1/2) 0 0 100 (1/1) 0 0 - -
Clinical pregnancy Yes No No Yes - - - -
No. of live birth ngoing - - ngoing - - - -

-,not applicable.

Figure 7. ICSI outcomes of DNAH3-deficient patients and Dnah3 KO mice.

Figure 7.

(A) The embryonic development of Patient 1 and Patient 3 after ICSI treatment. MII, metaphase II; PN, pronucleus; scale bars, 40 μm. (B) There was no difference in the fertilization rate or 2 cell and blastocyst embryo formation rates between the Dnah3 KO and WT groups (n=three biologically independent WT mice or KO mice; Student’s t test; NS, no significance; error bars, s.e.m.).

We also carried out ICSI treatment on Dnah3 KO male mice. Strikingly, favorable outcomes of ICSI were obtained in Dnah3 KO male mice. After injection of spermatozoa from Dnah3 KO male mice, pronuclei were observed in most embryos in both the KO and WT groups, indicating a normal fertilization rate (Figure 7B). There was no difference in the percentage of 2 cell and blastocyst-stage embryos between the KO and WT groups (Figure 7B). Collectively, we observed successful ICSI outcomes in two out of four DNAH3-deficient patients and Dnah3 KO male mice and therefore suggested ICSI as an optional treatment for infertile men harboring biallelic pathogenic variants in DNAH3, and the additional female risk factors for infertility should not be excluded in the failed patients.

Discussion

In the present study, we identified pathogenic variants in DNAH3 in unrelated infertile men with asthenoteratozoospermia. These variations resulted in the almost absence of DNAH3 and sharply decreased the expression of other IDA-associated proteins, including DNAH1, DNAH6 and DNALI1. Combined with similar findings in Dnah3 KO mice, we demonstrated that DNAH3 is fundamental for male fertility. Moreover, we suggest that ICSI might be a favorable treatment for male infertility caused by DNAH3 deficiency. Our findings identify a function for DNAH3 in male reproduction in humans and mice and may provide a new view on the clinical practice of male infertility.

Recently, Meng et al. reported DNAH3 mutations in asthenoteratozoospermia affected patients, revealing multiple morphological defects in sperm tail (Meng et al., 2024). Moreover, ultrastructural abnormalities of the flagellar axoneme in the patients were evident in these patients, characterized by a disrupted '9+2' arrangement and the notable absence of IDAs (Meng et al., 2024). Additionally, they generated Dnah3 KO mice, which were infertile and exhibited moderate morphological abnormalities (Meng et al., 2024). While the '9+2' microtubule arrangement in the flagella of their Dnah3 KO mice remained intact, the IDAs on the microtubules were partially absent (Meng et al., 2024). In our study, we observed similar phenotypic differences between DNAH3-deficient patients and Dnah3 KO mice. Both studies suggest that DNAH3 may play crucial yet distinct roles in human and mouse male reproduction.

However, there are notable differences between the two studies. Firstly, the phenotypes of Dnah3 KO mice showed slight differences. Meng et al. generated two Dnah3 KO mouse models (KO1 and KO2), and both of which exhibited significantly higher sperm motility and progressive motility than in our study (Meng et al., 2024), where nearly all sperm were completely immobile. Furthermore, their Dnah3 KO2 mice displayed motility comparable to WT mice and retained partial fertility (Meng et al., 2024). We speculate that these differences may be attributed to variations in mouse genetic background or the presence of a truncated DNAH3 protein resulting from specific knockout strategies. Secondly, we conducted additional research and uncovered novel findings. We revealed that male infertility caused by DNAH3 mutations follows an autosomal recessive inheritance pattern, as confirmed through Sanger sequencing of the patients' families. We also discovered the dynamic expression and localization of DNAH3 during spermatogenesis in humans and mice through immunofluorescent staining. Initially, DNAH3 was expressed in the cytoplasm of spermatogonia and spermatocytes, and then it clearly transferred into the flagellum of early and late spermatids. We further found that DNAH3 deficiency had no impact on ciliary development in the oviduct or on oogenesis in mice, resulting in normal female fertility. Moreover, in the absence of DNAH3 in both humans and mice, the expression of IDA-associated proteins, including DNAH1, DNAH6, and DNALI1, was decreased, while the expression of ODA-associated proteins remained unaffected, indicating that DNAH3 is involved in sperm axonemal development, specifically through its role in the assembly of IDAs. Collectively, our study corroborates the findings of Meng et al., and provides additional unique insights, comprehensively elucidating the critical role of DNAH3 in human and mouse spermatogenesis.

Primary ciliary dyskinesia (PCD, MIM: 244400) is a genetic disorder affecting at least one in 7554 individuals (Hannah et al., 2022). The most common symptoms of PCD are recurrent infections in airways due to malfunction of the motile cilia that are responsible for mucus clearance (O’Connor et al., 2023). It has been suggested that male infertility associated with sperm defects is highly prevalent (up to 75%) among individuals with PCD (Vanaken et al., 2017). Axonemal defects caused by variants within DNAH family members, including DNAH5, DNAH6, DNAH7, DNAH9 and DNAH11, are causative factors for PCD (Hornef et al., 2006; Guan et al., 2021; Peng et al., 2022). Moreover, deficiency in these PCD-causing DNAHs has also been associated with male infertility (Jiao et al., 2021; Sironen et al., 2020; Tu et al., 2019; Gao et al., 2022; Fliegauf et al., 2005; Fassad et al., 2018; Zuccarello et al., 2008). Additionally, other DNAHs, such as DNAH1, DNAH2, DNAH8, DNAH10, DNAH12, and DNAH17, are suggested to be pathogenic genes of isolated male infertility (Ben Khelifa et al., 2014; Hwang et al., 2021; Liu et al., 2020; Li et al., 2021; Whitfield et al., 2019). These phenotype–genotype correlations may be attributed to the fact that ciliary and flagellar axonemes have cell-type-specific or cell-type-enriched DNAHs (Wallmeier et al., 2020). DNAH3 resides in the IDA and is expressed in testis and ciliary tissues, including the lung, brain, eye, and oviduct. However, despite its presence in these tissues, the relationship between deficient DNAH3 and disease is unclear to date. Intriguingly, in our study, none of the patients with DNAH3 deficiency reported experiencing any of the principal symptoms associated with PCD. Additionally, our Dnah3 KO mice exhibited normal ciliary development in the lung, brain, eye, and oviduct. Similarly, Meng et al. did not mention any PCD symptoms in their DNAH3-deficient patients, and their Dnah3 KO mice also demonstrated normal ciliary morphology in the trachea and brain (Meng et al., 2024). These combined observations suggest that DNAH3 may play a more important role in sperm flagellar development than in other motile cilia functions. Given that DNAH3 is expressed in ciliary tissues, its role in these tissues remains intriguing and could be elucidated through sequencing of larger cohorts of individuals with PCD.

ICSI has been an efficient treatment for male infertility (Pan et al., 2018; Esteves et al., 2018). However, the outcomes of ICSI for male infertility caused by variants in different DNAH genes are variable. It has been demonstrated that infertile males with variants in DNAH1, DNAH2, DNAH7, and DNAH8 have a favorable prognosis (Liu et al., 2020; Long et al., 2023; Wambergue et al., 2016; Li et al., 2019; Gao et al., 2021; Wei et al., 2021), while patients with variants in DNAH17 have poor outcomes after ICSI treatment (Whitfield et al., 2019; Zheng et al., 2021). Meanwhile, the ICSI outcomes in male infertility caused by DNAH6 variants may depend on the specific mutation or be controversial (Tu et al., 2019; Huang et al., 2023; Li et al., 2018). The patients with DNAH3 mutations in our study experienced different clinical outcomes of ICSI treatment. The partners of Patient 1 and Patient 3 achieved clinical pregnancy. The wives of Patient 2 and Patient 4 obtained favorable fertilization and cleavage rates but experienced no clinical pregnancy due to the nonimplantation of the transferred embryos. Remarkably, despite the diverse variants within DNAH3 observed in the four patients, all variants led to a complete absence of DNAH3 expression. Additionally, we did not identify any pathogenic variants that associated with fertilization failure and early embryonic development in the two patients with failed ICSI outcomes. Therefore, these different ICSI outcomes might be attributed to additional unexplained factors from the female partners. Importantly, in the study from Meng et al., one patient carrying DNAH3 variants received ICSI treatment, and the partner obtained clinical pregnancy (Meng et al., 2024). Combined with the successful ICSI outcomes observed in Dnah3 KO mice, we suggest ICSI as an optimized treatment for infertile men carrying variants in DNAH3. More cases are needed to precisely estimate the prevalence of DNAH3 mutations and determine a prognosis for ICSI treatments.

In conclusion, our study revealed an unexplored role of DNAH3 in male reproduction in humans and mice, suggesting DNAH3 as a novel causative gene for human asthenoteratozoospermia. Moreover, ICSI is as an optimized treatment for infertile men with DNAH3 variants. This study expands our knowledge of the relationship between DNAH proteins and disease, facilitating genetic counseling and clinical treatment of male infertility in the future.

Materials and methods

Key resources table.

Reagent type (species) or resource Designation Source or reference Identifiers Additional information
Antibody Anti-DNAH1
(Rabbit polyclonal)
Cusabio CSB-PA878961LA01HU IF (1:100)
Antibody Anti-DNAH3
(Rabbit polyclonal)
Cusabio CSB-PA823461LA01HU IF (1:100)
Antibody Anti-DNAH3
(Rabbit polyclonal)
Gift from Prof. Yueqiu Tan, Central South University, China. WB (1:200)
Antibody Anti-DNAH6
(Rabbit polyclonal)
Proteintech 18080–1-AP,
RRID: AB_2878493
IF (1:50),
WB (1:150)
Antibody Anti-DNAH8
(Rabbit polyclonal)
Atlas HPA028447,
RRID: AB_10599600
IF (1:200)
Antibody Anti-DNAH17
(Rabbit polyclonal)
Proteintech 24488–1-AP,
RRID: AB_2879568
IF (1:50)
Antibody Anti-DNAI1
(Rabbit polyclonal)
Proteintech 12756–1-AP,
RRID: AB_10643244
IF (1:50)
Antibody Anti-DNALI1
(Rabbit polyclonal)
Proteintech 17601–1-AP,
RRID: AB_2095372
IF (1:50),
WB (1:150)
Antibody Anti-TOM20
(Rabbit polyclonal)
Proteintech 11802–1-AP,
RRID: AB_2207530
IF (1:50)
Antibody Anti-SLC25A4
(Rabbit polyclonal)
Signalway 32484,
RRID: AB_2941094
IF (1:100)
Antibody Anti-alpha tubulin
(Mouse monoclonal)
Abcam ab7291,
RRID: AB_2241126
IF (1:500)
Antibody Anti-alpha tubulin
(Rabbit polyclonal)
Proteintech 11224–1-AP,
RRID: AB_2210206
WB (1:1000)
Antibody Anti-Rabbit IgG,
Alexa Fluor 488
(Goat polyclonal)
Invitrogen A11008,
RRID: AB_143165
IF (1:1000)
Antibody Anti-Mouse IgG,
Alexa Fluor 594
(Goat polyclonal)
Invitrogen A11005,
RRID: AB_141372
IF (1:1000)
Antibody Anti-acetylated alpha tubulin
(Mouse monoclonal)
Abcam ab24610,
RRID: AB_448182
IF (1:500)
Antibody Anti-Mouse IgG,
HRP-conjugated
(Goat polyclonal)
Proteintech SA00001-1,
RRID: AB_2722565
WB (1:5000)
Antibody Anti-Rabbit IgG,
HRP-conjugated
(Goat polyclonal)
Proteintech SA00001-2,
RRID: AB_2722564
WB (1:5000)
Other Lectin PNA Invitrogen L-32460 IF (1:50)

Human subjects

Four unrelated Han Chinese infertile men and their family members were recruited from West China Second University Hospital of Sichuan University and Women and Children’s Hospital of Chongqing Medical University. All patients exhibited a normal karyotype (46 XY) without deletion of the azoospermia factor (AZF) region in the Y-chromosome. All of the participants were provided informed consent, and the study was approved by the ethics committee of West China Second University Hospital.

Genetic analysis

Peripheral blood samples were obtained from the subjects to extract genomic DNA using a DNA purification kit (TIANGEN, DP304). For WES, 1 μg of genomic DNA was utilized for exon capture using the Agilent SureSelect Human All Exon V6 Kit and sequenced on the Illumina HiSeq X system (150 bp read length). The quality of WES, including clean reads, sequencing depth, sequencing coverage, and mapping quality are listed in Figure 1—source data 1. The variants identified through WES were annotated and filtered using Exomiser. Next, the variants were screened to obtain candidate variants based on the following criteria: (Cox et al., 2022) the allele frequency in the East Asian population was less than 1% in any database, including the ExAC Browser, gnomAD, and the 1000 Genomes Project; (Eisenberg et al., 2023) the variants affected coding exons or canonical splice sites; (Agarwal et al., 2015) the variants were predicted to be possibly pathogenic or damaging. The remain genes were then analyzed using the Human Protein Atlas (HPA) database (https://www.proteinatlas.org/) and Mouse Genome Informatics (MGI) database (https://informatics.jax.org/) to access their expression in human and mouse testis. Additionally, OMIM database (https://www.omim.org/) and relevant literature were used to understand their relationship with human infertility. Given the assumption of a recessive inheritance pattern, monoallelic variants were excluded from consideration. The remained candidate pathogenic variants were verified by Sanger sequencing on DNA from the patients' families.

Electron microscopy

For scanning electron microscopy (SEM), sperm samples were fixed in glutaraldehyde (2.5%, w/v) and dehydrated using an ethanol gradient (30, 50, 75, 85, 95, and 100% ethanol). The samples were dried using a CO2 critical-point dryer (Eiko HCP-2, Hitachi) and observed under SEM (S-3400, Hitachi).

For transmission electron microscopy (TEM), sperm samples were fixed in glutaraldehyde (3%, w/v) and osmium tetroxide (1%, w/v) and dehydrated with an ethanol gradient. The samples were embedded in Epon 812. Ultrathin sections were stained with uranyl acetate and lead citrate and analyzed under TEM (Tecnai G2 F20).

STA-PUT velocity sedimentation

Single testicular cells from obstructive azoospermia and 8-week-old C57BL male mice were obtained using the STA-PUT velocity sedimentation method as described previously (Liu et al., 2015; Chang et al., 2011). In brief, total spermatogenic cells were harvested by digesting seminiferous tubules with collagenase (Invitrogen, 17100017), trypsin (Sigma, T4799) and DNase (Promega, M6101) for 15 min each at 37 °C. Cells were diluted in bovine serum albumin (BSA, 3%, w/v) and filtered through an 80 mm mesh to remove fragments. Then, the cells were resuspended in BSA (3%, w/v) and loaded into an STA-PUT velocity sedimentation cell separator (ProScience) to obtain germ cells at different stages.

RNA isolation and quantitative PCR (qPCR)

Total RNA of mouse tissues was extracted using TRIzol reagent (Invitrogen,15596026,) and reverse-transcribed using the 1st Strand cDNA Synthesis Kit (Yeasen, HB210629) according to the manufacturer’s instructions. qPCR was carried out on an iCycler RT‒PCR Detection System (Bio-Rad Laboratories) using SYBR Green qPCR Master Mix (Bimake, B21202).

Immunofluorescence staining

Sperm samples were fixed in paraformaldehyde (4%, w/v), permeabilized with Triton X-100 (0.3% v/v) and blocked with BSA (3%, w/v) at room temperature. Samples were incubated with primary antibodies overnight at 4 °C. The next day, the samples were washed and incubated with the secondary antibody, and the nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI, Sigma‒Aldrich, D9542). Image capture was performed by a laser scanning confocal microscope (Olympus, FV3000).

For staining of mouse tissues, samples were first fixed in paraformaldehyde (4%, w/v) and dehydrated with an ethanol gradient. Then, the samples were embedded in paraffin and sliced into 5 μm sections. After deparaffinization and rehydration, sections were processed with 3% hydrogen peroxide and incubated in sodium citrate for antigen repair. Subsequently, sections were blocked with goat serum and incubated with primary antibodies at 4 °C overnight. The next day, the sections were incubated with the secondary antibody, followed by labeling the nuclei with DAPI. Image capture was performed using a fluorescence microscope (Zeiss, Ax10).

Western blotting

Sperm samples were lysed in RIPA buffer (Beyotime, P0013B) to extract the total protein. For analysis of DNALI1, the protein samples were mixed with SDS loading buffer (P0015, Beyotime, China), boiled at 95 °C for 5 min, and separated by 12.5% SDS-PAGE. For analysis of DNAH1, DNAH3, DNAH6, the protein samples were mixed with NuPAGE LDS sample buffer (Invitrogen, NP0007), denatured at 70 °C for 10 min, and separated by 3–8% NuPAGE Tris-Acetate gels (EA0375BOX, Invitrogen). Then the resolved proteins were transferred to 0.45 μm PVDF membranes (Merck Millipore, IPVH00010). The membranes were blocked, incubated with primary antibodies at 4°C overnight. The following day, membranes were washed and incubated with HRP-conjugated secondary antibody. Protein bands were visualized using enhanced chemiluminescence reagents (Millipore, WBKLS0500).

Histology hematoxylin-eosin (H&E) staining

Tissue samples from mice were fixed with 4% paraformaldehyde (w/v) overnight. Following dehydration by ethanol, the samples were embedded in paraffin and sliced into 5 μm sections. The sections were stained with hematoxylin and eosin and observed under a microscope (Zeiss, Axio Imager 2).

Generation of the Dnah3 KO mouse model

Animal experiments in this study were approved by the Experimental Animal Management and Ethics Committee of West China Second University Hospital, Sichuan University (No. 20230150), and complied with the Animal Care and Use Committee of Sichuan University. A Dnah3 knockout mouse model was generated by the CRISPR‒Cas9 system. Briefly, Cas9 and signal-guide RNAs (5’-GTATCAAGTGGATGTAAACC-3’) were transcribed using T7 RNA polymerase in vitro and comicroinjected into the cytoplasm of single-cell C57BL/6 J mouse embryos to generate frameshift mutations by nonhomologous recombination through introduction of a 1 bp insertion in exon 13. Then, the embryos were cultured and transferred into the oviducts of pseudopregnant female mice at 0.5 days post-coitum. A mutation of Dnah3 in the founder mouse and their offspring was confirmed using PCR and Sanger sequencing.

Intracytoplasmic sperm injection (ICSI)

ICSI was carried out using standard techniques. In brief, one-month-old female KM mice were injected with 5 IU of equine chorionic gonadotropin (eCG) (ProSpec, HOR-272) to induce superovulation. Metaphase II-arrested (MII) oocytes were acquired through another injection of 5 IU human chorionic gonadotropin after 48 hr. MII oocytes were incubated with Chatot-Ziomek-Bavister medium (Easycheck, M2750) at 37.5 °C and 5% CO2 until use. Mouse cauda epididymal spermatozoa were incubated in human tubal fluid (HTF) medium (Easycheck, M1150) and then frozen and thawed repeatedly to remove sperm tails. For ICSI, a single sperm head was microinjected into an MII oocyte by using a NIKON inverted microscope and a Piezo (PrimeTech, Osaka, Japan) in Whitten’s-HEPES medium containing 0.01% polyvinyl alcohol (Gibco,12360–038) and cytochalasin B (3.5 g/ml; Sigma‒Aldrich, C-6762). The successfully injected oocytes were transferred into G1-Plus medium (Vitrolife, 10132) and incubated at 37.5 °C and 5% CO2. The animal experiments were approved by the Experimental Animal Management and Ethics Committee of West China Second University Hospital, Sichuan University.

Statistical analysis

Prism (version 8.4.0, GraphPad, Boston, MA, USA) and SPSS (version 18.0, IBM Corporation, Armonk, NY, USA) were used to perform statistical analyses. All data are presented as the means ± SEMs. Data from two groups were compared using an unpaired, parametric, two-sided Student’s t test, and a p value less than 0.05 was considered statistically significant.

Acknowledgements

The authors thank the patients and their family members for their voluntary participation. We are grateful to Guiping Yuan (Analytical and Testing Center of Sichuan University) and Yan Liang (Research Core Facility of West China Hospital, Sichuan University) for their help with TEM images and preparing histology slides. We are grateful to Prof. Yueqiu Tan (Central South University, Changsha, China) for providing the anti-DNAH3 antibody. This work was supported by National Natural Science Foundation of China (82301807).

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Tingting Lin, Email: yuting9263@163.com.

Ying Shen, Email: yingcaishen01@163.com.

Izuchukwu Okafor, Nnamdi Azikiwe University, Nigeria.

Wei Yan, The Lundquist Institute, United States.

Funding Information

This paper was supported by the following grant:

  • National Natural Science Foundation of China 82301807 to Tingting Lin.

Additional information

Competing interests

No competing interests declared.

Author contributions

Data curation, Formal analysis, Investigation, Methodology, Writing – original draft.

Data curation, Formal analysis.

Resources, Investigation, Methodology.

Data curation, Formal analysis.

Formal analysis, Methodology.

Validation, Methodology.

Investigation.

Investigation, Methodology.

Investigation.

Investigation.

Methodology.

Investigation.

Conceptualization, Supervision, Funding acquisition, Project administration, Writing – review and editing.

Conceptualization, Supervision, Project administration, Writing – review and editing.

Ethics

This study was approved by Ethical Review Board of West China Second University Hospital, Sichuan University (No. 2023160). Informed consent was obtained from each participate in this study before taking part.

The animal experiments were approved by the Experimental Animal Management and Ethics Committee of West China Second University Hospital, Sichuan University (No. 2023150).

Additional files

MDAR checklist

Data availability

The published article includes all datasets generated or analyzed during this study. The whole exome-sequencing data were deposited in the National Genomics Data Center (NGDC) (https://ngdc.cncb.ac.cn/, accession number: HRA007467).

The following dataset was generated:

Wang X, Shen G, Yang Y, Jiang C, Ruan T, Yang X, Zhuo L, Zhang Y, Ou Y, Zhao X, Long S, Tang X, Lin T, Shen Y. 2024. DNAH3 deficiency causes flagellar inner dynein arm loss and male infertility in humans and mice. NGDC Genome Sequence Archive for Human. HRA007467

References

  1. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR. A method and server for predicting damaging missense mutations. Nature Methods. 2010;7:248–249. doi: 10.1038/nmeth0410-248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agarwal A, Mulgund A, Hamada A, Chyatte MR. A unique view on male infertility around the globe. Reproductive Biology and Endocrinology. 2015;13:37. doi: 10.1186/s12958-015-0032-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aprea I, Raidt J, Höben IM, Loges NT, Nöthe-Menchen T, Pennekamp P, Olbrich H, Kaiser T, Biebach L, Tüttelmann F, Horvath J, Schubert M, Krallmann C, Kliesch S, Omran H. Defects in the cytoplasmic assembly of axonemal dynein arms cause morphological abnormalities and dysmotility in sperm cells leading to male infertility. PLOS Genetics. 2021;17:e1009306. doi: 10.1371/journal.pgen.1009306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ben Khelifa M, Coutton C, Zouari R, Karaouzène T, Rendu J, Bidart M, Yassine S, Pierre V, Delaroche J, Hennebicq S, Grunwald D, Escalier D, Pernet-Gallay K, Jouk P-S, Thierry-Mieg N, Touré A, Arnoult C, Ray PF. Mutations in DNAH1, which encodes an inner arm heavy chain dynein, lead to male infertility from multiple morphological abnormalities of the sperm flagella. American Journal of Human Genetics. 2014;94:95–104. doi: 10.1016/j.ajhg.2013.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Burgess SA, Walker ML, Sakakibara H, Knight PJ, Oiwa K. Dynein structure and power stroke. Nature. 2003;421:715–718. doi: 10.1038/nature01377. [DOI] [PubMed] [Google Scholar]
  6. Chang YF, Lee-Chang JS, Panneerdoss S, Rao MK. Isolation of Sertoli, Leydig, and spermatogenic cells from the mouse testis. BioTechniques. 2011;51:341–342. doi: 10.2144/000113764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chapelin C, Duriez B, Magnino F, Goossens M, Escudier E, Amselem S. Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment. FEBS Letters. 1997;412:325–330. doi: 10.1016/s0014-5793(97)00800-4. [DOI] [PubMed] [Google Scholar]
  8. Colpi GM, Francavilla S, Haidl G, Link K, Behre HM, Goulis DG, Krausz C, Giwercman A. European Academy of Andrology guideline Management of oligo-astheno-teratozoospermia. Andrology. 2018;6:513–524. doi: 10.1111/andr.12502. [DOI] [PubMed] [Google Scholar]
  9. Cox CM, Thoma ME, Tchangalova N, Mburu G, Bornstein MJ, Johnson CL, Kiarie J. Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis. Human Reproduction Open. 2022;2022:hoac051. doi: 10.1093/hropen/hoac051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eisenberg ML, Esteves SC, Lamb DJ, Hotaling JM, Giwercman A, Hwang K, Cheng YS. Male infertility. Nature Reviews. Disease Primers. 2023;9:49. doi: 10.1038/s41572-023-00459-w. [DOI] [PubMed] [Google Scholar]
  11. Esteves SC, Roque M, Bedoschi G, Haahr T, Humaidan P. Intracytoplasmic sperm injection for male infertility and consequences for offspring. Nature Reviews. Urology. 2018;15:535–562. doi: 10.1038/s41585-018-0051-8. [DOI] [PubMed] [Google Scholar]
  12. Fassad MR, Shoemark A, Legendre M, Hirst RA, Koll F, le Borgne P, Louis B, Daudvohra F, Patel MP, Thomas L, Dixon M, Burgoyne T, Hayes J, Nicholson AG, Cullup T, Jenkins L, Carr SB, Aurora P, Lemullois M, Aubusson-Fleury A, Papon J-F, O’Callaghan C, Amselem S, Hogg C, Escudier E, Tassin A-M, Mitchison HM. Mutations in outer dynein arm heavy chain DNAH9 cause motile cilia defects and situs inversus. American Journal of Human Genetics. 2018;103:984–994. doi: 10.1016/j.ajhg.2018.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fliegauf M, Olbrich H, Horvath J, Wildhaber JH, Zariwala MA, Kennedy M, Knowles MR, Omran H. Mislocalization of DNAH5 and DNAH9 in respiratory cells from patients with primary ciliary dyskinesia. American Journal of Respiratory and Critical Care Medicine. 2005;171:1343–1349. doi: 10.1164/rccm.200411-1583OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gao Y, Tian S, Sha Y, Zha X, Cheng H, Wang A, Liu C, Lv M, Ni X, Li Q, Wu H, Tan Q, Tang D, Song B, Ding D, Cong J, Xu Y, Zhou P, Wei Z, Cao Y, Xu Y, Zhang F, He X. Novel bi-allelic variants in DNAH2 cause severe asthenoteratozoospermia with multiple morphological abnormalities of the flagella. Reproductive Biomedicine Online. 2021;42:963–972. doi: 10.1016/j.rbmo.2021.01.011. [DOI] [PubMed] [Google Scholar]
  15. Gao Y, Liu L, Shen Q, Fu F, Xu C, Geng H, Lv M, Li K, Tang D, Song B, Wu H, Xu Y, Zhang Y, Tao F, Zhou P, Wei Z, He X, Cao Y. Loss of function mutation in DNAH7 induces male infertility associated with abnormalities of the sperm flagella and mitochondria in human. Clinical Genetics. 2022;102:130–135. doi: 10.1111/cge.14146. [DOI] [PubMed] [Google Scholar]
  16. Guan Y, Yang H, Yao X, Xu H, Liu H, Tang X, Hao C, Zhang X, Zhao S, Ge W, Ni X. Clinical and genetic spectrum of children with primary ciliary dyskinesia in china. Chest. 2021;159:1768–1781. doi: 10.1016/j.chest.2021.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gunes S, Sengupta P, Henkel R, Alguraigari A, Sinigaglia MM, Kayal M, Joumah A, Agarwal A. Microtubular dysfunction and male infertility. The World Journal of Men’s Health. 2020;38:9–23. doi: 10.5534/wjmh.180066. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hamdi Y, Boujemaa M, Ben Rekaya M, Ben Hamda C, Mighri N, El Benna H, Mejri N, Labidi S, Daoud N, Naouali C, Messaoud O, Chargui M, Ghedira K, Boubaker MS, Mrad R, Boussen H, Abdelhak S, PEC Consortium Family specific genetic predisposition to breast cancer: results from Tunisian whole exome sequenced breast cancer cases. Journal of Translational Medicine. 2018;16:158. doi: 10.1186/s12967-018-1504-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hannah WB, Seifert BA, Truty R, Zariwala MA, Ameel K, Zhao Y, Nykamp K, Gaston B. The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis. The Lancet. Respiratory Medicine. 2022;10:459–468. doi: 10.1016/S2213-2600(21)00453-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hornef N, Olbrich H, Horvath J, Zariwala MA, Fliegauf M, Loges NT, Wildhaber J, Noone PG, Kennedy M, Antonarakis SE, Blouin J-L, Bartoloni L, Nüsslein T, Ahrens P, Griese M, Kuhl H, Sudbrak R, Knowles MR, Reinhardt R, Omran H. DNAH5 mutations are a common cause of primary ciliary dyskinesia with outer dynein arm defects. American Journal of Respiratory and Critical Care Medicine. 2006;174:120–126. doi: 10.1164/rccm.200601-084OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Houston BJ, Riera-Escamilla A, Wyrwoll MJ, Salas-Huetos A, Xavier MJ, Nagirnaja L, Friedrich C, Conrad DF, Aston KI, Krausz C, Tüttelmann F, O’Bryan MK, Veltman JA, Oud MS. A systematic review of the validated monogenic causes of human male infertility: 2020 update and A discussion of emerging gene-disease relationships. Human Reproduction Update. 2021;28:15–29. doi: 10.1093/humupd/dmab030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Huang F, Zeng J, Liu D, Zhang J, Liang B, Gao J, Yan R, Shi X, Chen J, Song W, Huang HL. A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia. Frontiers in Endocrinology. 2023;14:1122004. doi: 10.3389/fendo.2023.1122004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hwang JY, Nawaz S, Choi J, Wang H, Hussain S, Nawaz M, Lopez-Giraldez F, Jeong K, Dong W, Oh J-N, Bilguvar K, Mane S, Lee C-K, Bystroff C, Lifton RP, Ahmad W, Chung J-J. Genetic defects in DNAH2 underlie male infertility with multiple morphological abnormalities of the sperm flagella in humans and mice. Frontiers in Cell and Developmental Biology. 2021;9:662903. doi: 10.3389/fcell.2021.662903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jiao SY, Yang YH, Chen SR. Molecular genetics of infertility: loss-of-function mutations in humans and corresponding knockout/mutated mice. Human Reproduction Update. 2021;27:154–189. doi: 10.1093/humupd/dmaa034. [DOI] [PubMed] [Google Scholar]
  25. Karak S, Jacobs JS, Kittelmann M, Spalthoff C, Katana R, Sivan-Loukianova E, Schon MA, Kernan MJ, Eberl DF, Göpfert MC. Diverse roles of axonemal dyneins in Drosophila auditory neuron function and mechanical amplification in hearing. Scientific Reports. 2015;5:17085. doi: 10.1038/srep17085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. King SM. Axonemal Dynein Arms. Cold Spring Harbor Perspectives in Biology. 2016;8:a028100. doi: 10.1101/cshperspect.a028100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Leung MR, Zeng J, Wang X, Roelofs MC, Huang W, Zenezini Chiozzi R, Hevler JF, Heck AJR, Dutcher SK, Brown A, Zhang R, Zeev-Ben-Mordehai T. Structural specializations of the sperm tail. Cell. 2023;186:2880–2896. doi: 10.1016/j.cell.2023.05.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Li L, Sha YW, Xu X, Mei LB, Qiu PP, Ji ZY, Lin SB, Su ZY, Wang C, Yin C, Li P. DNAH6 is a novel candidate gene associated with sperm head anomaly. Andrologia. 2018;01:12953. doi: 10.1111/and.12953. [DOI] [PubMed] [Google Scholar]
  29. Li Y, Sha Y, Wang X, Ding L, Liu W, Ji Z, Mei L, Huang X, Lin S, Kong S, Lu J, Qin W, Zhang X, Zhuang J, Tang Y, Lu Z. DNAH2 is a novel candidate gene associated with multiple morphological abnormalities of the sperm flagella. Clinical Genetics. 2019;95:590–600. doi: 10.1111/cge.13525. [DOI] [PubMed] [Google Scholar]
  30. Li Y, Wang Y, Wen Y, Zhang T, Wang X, Jiang C, Zheng R, Zhou F, Chen D, Yang Y, Shen Y. Whole-exome sequencing of a cohort of infertile men reveals novel causative genes in teratozoospermia that are chiefly related to sperm head defects. Human Reproduction. 2021;37:152–177. doi: 10.1093/humrep/deab229. [DOI] [PubMed] [Google Scholar]
  31. Linck RW, Chemes H, Albertini DF. The axoneme: the propulsive engine of spermatozoa and cilia and associated ciliopathies leading to infertility. Journal of Assisted Reproduction and Genetics. 2016;33:141–156. doi: 10.1007/s10815-016-0652-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Liu Y, Niu M, Yao C, Hai Y, Yuan Q, Liu Y, Guo Y, Li Z, He Z. Fractionation of human spermatogenic cells using STA-PUT gravity sedimentation and their miRNA profiling. Scientific Reports. 2015;5:8084. doi: 10.1038/srep08084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Liu C, Miyata H, Gao Y, Sha Y, Tang S, Xu Z, Whitfield M, Patrat C, Wu H, Dulioust E, Tian S, Shimada K, Cong J, Noda T, Li H, Morohoshi A, Cazin C, Kherraf Z-E, Arnoult C, Jin L, He X, Ray PF, Cao Y, Touré A, Zhang F, Ikawa M. Bi-allelic DNAH8 variants lead to multiple morphological abnormalities of the sperm flagella and primary male infertility. American Journal of Human Genetics. 2020;107:330–341. doi: 10.1016/j.ajhg.2020.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Long S, Fu L, Ma J, Yu H, Tang X, Han W, Liu W, Huang G, Lu W, Lin T. O-253 Novel biallelic variants in DNAH1 cause multiple morphological abnormalities of sperm flagella with favorable outcomes of fertility after ICSI in Han Chinese males. Human Reproduction. 2023;38:dead093.307. doi: 10.1093/humrep/dead093.307. [DOI] [PubMed] [Google Scholar]
  35. Lu S, Gu Y, Wu Y, Yang S, Li C, Meng L, Yuan W, Jiang T, Zhang X, Li Y, Wang C, Liu M, Ye L, Guo X, Shen H, Yang X, Tan Y, Hu Z. Bi-allelic variants in human WDR63 cause male infertility via abnormal inner dynein arms assembly. Cell Discovery. 2021;7:110. doi: 10.1038/s41421-021-00327-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Meng G-Q, Wang Y, Luo C, Tan Y-M, Li Y, Tan C, Tu C, Zhang Q-J, Hu L, Zhang H, Meng L-L, Liu C-Y, Deng L, Lu G-X, Lin G, Du J, Tan Y-Q, Sha Y, Wang L, He W-B. Bi-allelic variants in DNAH3 cause male infertility with asthenoteratozoospermia in humans and mice. Human Reproduction Open. 2024;2024:hoae003. doi: 10.1093/hropen/hoae003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Modiba MC, Nephawe KA, Mdladla KH, Lu W, Mtileni B. Candidate genes in bull semen production traits: An information approach review. Veterinary Sciences. 2022;9:155. doi: 10.3390/vetsci9040155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Research. 2003;31:3812–3814. doi: 10.1093/nar/gkg509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. O’Connor MG, Mosquera R, Metjian H, Marmor M, Olivier KN, Shapiro AJ. Primary ciliary dyskinesia. CHEST Pulmonary. 2023;1:100004. doi: 10.1016/j.chpulm.2023.100004. [DOI] [Google Scholar]
  40. Pan MM, Hockenberry MS, Kirby EW, Lipshultz LI. Male infertility diagnosis and treatment in the era of in vitro fertilization and intracytoplasmic sperm injection. The Medical Clinics of North America. 2018;102:337–347. doi: 10.1016/j.mcna.2017.10.008. [DOI] [PubMed] [Google Scholar]
  41. Peng B, Gao YH, Xie JQ, He XW, Wang CC, Xu JF, Zhang GJ. Clinical and genetic spectrum of primary ciliary dyskinesia in Chinese patients: a systematic review. Orphanet Journal of Rare Diseases. 2022;17:283. doi: 10.1186/s13023-022-02427-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Research. 2019;47:D886–D894. doi: 10.1093/nar/gky1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nature Methods. 2014;11:361–362. doi: 10.1038/nmeth.2890. [DOI] [PubMed] [Google Scholar]
  44. Sironen A, Shoemark A, Patel M, Loebinger MR, Mitchison HM. Sperm defects in primary ciliary dyskinesia and related causes of male infertility. Cellular and Molecular Life Sciences. 2020;77:2029–2048. doi: 10.1007/s00018-019-03389-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Touré A, Martinez G, Kherraf Z-E, Cazin C, Beurois J, Arnoult C, Ray PF, Coutton C. The genetic architecture of morphological abnormalities of the sperm tail. Human Genetics. 2021;140:21–42. doi: 10.1007/s00439-020-02113-x. [DOI] [PubMed] [Google Scholar]
  46. Tsai CC, Huang FJ, Wang LJ, Lin YJ, Kung FT, Hsieh CH, Lan KC. Clinical outcomes and development of children born after intracytoplasmic sperm injection (ICSI) using extracted testicular sperm or ejaculated extreme severe oligo-astheno-teratozoospermia sperm: a comparative study. Fertility and Sterility. 2011;96:567–571. doi: 10.1016/j.fertnstert.2011.06.080. [DOI] [PubMed] [Google Scholar]
  47. Tu C, Nie H, Meng L, Yuan S, He W, Luo A, Li H, Li W, Du J, Lu G, Lin G, Tan Y-Q. Identification of DNAH6 mutations in infertile men with multiple morphological abnormalities of the sperm flagella. Scientific Reports. 2019;9:15864. doi: 10.1038/s41598-019-52436-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Tu C, Cong J, Zhang Q, He X, Zheng R, Yang X, Gao Y, Wu H, Lv M, Gu Y, Lu S, Liu C, Tian S, Meng L, Wang W, Tan C, Nie H, Li D, Zhang H, Gong F, Hu L, Lu G, Xu W, Lin G, Zhang F, Cao Y, Tan Y-Q. Bi-allelic mutations of DNAH10 cause primary male infertility with asthenoteratozoospermia in humans and mice. American Journal of Human Genetics. 2021;108:1466–1477. doi: 10.1016/j.ajhg.2021.06.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Vanaken GJ, Bassinet L, Boon M, Mani R, Honoré I, Papon J-F, Cuppens H, Jaspers M, Lorent N, Coste A, Escudier E, Amselem S, Maitre B, Legendre M, Christin-Maitre S. Infertility in an adult cohort with primary ciliary dyskinesia: phenotype-gene association. The European Respiratory Journal. 2017;50:1700314. doi: 10.1183/13993003.00314-2017. [DOI] [PubMed] [Google Scholar]
  50. Wallmeier J, Nielsen KG, Kuehni CE, Lucas JS, Leigh MW, Zariwala MA, Omran H. Motile ciliopathies. Nature Reviews. Disease Primers. 2020;6:77. doi: 10.1038/s41572-020-0209-6. [DOI] [PubMed] [Google Scholar]
  51. Walton T, Gui M, Velkova S, Fassad MR, Hirst RA, Haarman E, O’Callaghan C, Bottier M, Burgoyne T, Mitchison HM, Brown A. Axonemal structures reveal mechanoregulatory and disease mechanisms. Nature. 2023;618:625–633. doi: 10.1038/s41586-023-06140-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Wambergue C, Zouari R, Fourati Ben Mustapha S, Martinez G, Devillard F, Hennebicq S, Satre V, Brouillet S, Halouani L, Marrakchi O, Makni M, Latrous H, Kharouf M, Amblard F, Arnoult C, Ray PF, Coutton C. Patients with multiple morphological abnormalities of the sperm flagella due to DNAH1 mutations have a good prognosis following intracytoplasmic sperm injection. Human Reproduction. 2016;31:1164–1172. doi: 10.1093/humrep/dew083. [DOI] [PubMed] [Google Scholar]
  53. Wang WL, Tu CF, Tan YQ. Insight on multiple morphological abnormalities of sperm flagella in male infertility: what is new? Asian Journal of Andrology. 2020;22:236–245. doi: 10.4103/aja.aja_53_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Wang J, Wang W, Shen L, Zheng A, Meng Q, Li H, Yang S. Clinical detection, diagnosis and treatment of morphological abnormalities of sperm flagella: A review of literature. Frontiers in Genetics. 2022;13:1034951. doi: 10.3389/fgene.2022.1034951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wei X, Sha Y, Wei Z, Zhu X, He F, Zhang X, Liu W, Wang Y, Lu Z. Bi-allelic mutations in DNAH7 cause asthenozoospermia by impairing the integrality of axoneme structure. Acta Biochimica et Biophysica Sinica. 2021;53:1300–1309. doi: 10.1093/abbs/gmab113. [DOI] [PubMed] [Google Scholar]
  56. Whitfield M, Thomas L, Bequignon E, Schmitt A, Stouvenel L, Montantin G, Tissier S, Duquesnoy P, Copin B, Chantot S, Dastot F, Faucon C, Barbotin AL, Loyens A, Siffroi J-P, Papon J-F, Escudier E, Amselem S, Mitchell V, Touré A, Legendre M. Mutations in DNAH17, encoding a sperm-specific axonemal outer dynein arm heavy chain, cause isolated male infertility due to asthenozoospermia. American Journal of Human Genetics. 2019;105:198–212. doi: 10.1016/j.ajhg.2019.04.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Zheng R, Sun Y, Jiang C, Chen D, Yang Y, Shen Y. A novel mutation in DNAH17 is present in A patient with multiple morphological abnormalities of the flagella. Reproductive Biomedicine Online. 2021;43:532–541. doi: 10.1016/j.rbmo.2021.05.009. [DOI] [PubMed] [Google Scholar]
  58. Zuccarello D, Ferlin A, Cazzadore C, Pepe A, Garolla A, Moretti A, Cordeschi G, Francavilla S, Foresta C. Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. Human Reproduction. 2008;23:1957–1962. doi: 10.1093/humrep/den193. [DOI] [PubMed] [Google Scholar]

eLife Assessment

Izuchukwu Okafor 1

This important study identifies biallelic variants of DNAH3 in unrelated infertile men and reports infertility in DNAH3 knockout mice. The authors demonstrate that compromised DNAH3 activity decreases the expression of IDA-associated proteins in the spermatozoa of human patients and knockout mice, providing convincing evidence that DNAH3 is a novel pathogenic gene for asthenoteratozoospermia and male infertility. The study will be of substantial interest to clinicians, reproductive counselors, embryologists, and basic researchers working on infertility and assisted reproductive technology.

Reviewer #1 (Public review):

Anonymous

Summary:

Wang and colleagues identify biallelic variants of DNAH3 in four unrelated Han Chinese infertile men through whole-exome sequencing, which contributes to abnormal sperm flagellar morphology and ultrastructure. To investigate the importance of DNAH3 in male infertility, the authors generated crispant Dnah3 knockout (KO) male mice. They observed that KO mice are also infertile, showing a severe reduction in sperm movement with abnormal IDA (inner dynein arms) and mitochondrion structure. Moreover, nonfunctional DNAH3 expression decreased the expression of IDA-associated proteins in the spermatozoa of patients and KO mice, which are involved in the disruption of sperm motility. Interestingly, the infertility of patients and KO mice is rescued by intracytoplasmic sperm injection (ICSI). Taken together, the authors propose that DNAH3 is a novel pathogenic gene for asthenoterozoospermia and male infertility.

Strengths:

This work investigates the role of DNAH3 in sperm mobility and male infertility. By using gold-standard molecular biology techniques, the authors demonstrate with exquisite resolution the importance of DNAH3 in sperm morphology, showing strong evidence of its role in male infertility. Overall, this is a very interesting, well-written, and appealing article. All aspects of the study design and methods are well described and appropriate to address the main question of the manuscript. The conclusions drawn are consistent with the analyses conducted and supported by the data.

Weaknesses:

The paper is solid, and in its current form, I have not detected relevant weaknesses.

Reviewer #2 (Public review):

Anonymous

Wang et al. investigated the role of dynein axonemal heavy chain 3 (DNAH3) in male infertility. They found that variants of DNAH3 were present in four infertile men, and the deficiency of DNAH3 in sperm affects sperm mobility. Additionally, they showed that Dnah3 knockout male mice are infertile. Furthermore, they demonstrated that DNAH3 influences inner dynein arms by regulating several DNAH proteins. Importantly, they showed that intracytoplasmic sperm injection (ICSI) can rescue the infertility in Dnah3 knockout mice and two patients with DNAH3 variants.

Strengths:

The conclusions of this paper are well-supported by data.

Weaknesses:

The sample/patient size is small; however, the findings are consistent with those of a recent study on DNAH3 in male infertility with 432 patients.

Reviewer #3 (Public review):

Anonymous

Summary:

(1) To further explore the genetic basis of asthenoteratozoospermia, the authors performed whole-exome sequencing analyses among infertile males affected by asthenoteratozoospermia. Four unrelated Han Chinese patients were found to carry biallelic variations of DNAH3, a gene encoding IDA-associated protein.

(2) To verify the function of IDA associated protein DNAH3, the authors generated a Dnah3-KO mouse model and revealed that the loss of DNAH3 leads to severe male infertility as a result of the severe reduction in sperm movement with the abnormal IDA and mitochondrion structures.

(3) Mechanically, they confirmed decreased expression of IDA-associated proteins (including DNAH1, DNAH6 and DNALI1) in the spermatozoa from patients with DNAH3 mutations and Dnah3-KO male mice.

(4) Then, they also found that male infertility caused by DNAH3 deficiency could be rescued by intracytoplasmic sperm injection (ICSI) treatment in humans and mice.

Strengths:

(1) In addition to existing research, the authors provided novel variants of DNAH3 as important factors leading to asthenoteratozoospermia. This further expands the spectrum of pathogenic variants in asthenoteratozoospermia.

(2) By mechanistic studies, they found that DNAH3 deficiency led to decreased expression of IDA-associated proteins, which may be used to explain the disruption of sperm motility and reduced fertility caused by DNAH3 deficiency.

(3) Then, successful ICSI outcomes were observed in patients with DNAH3 mutations and Dnah3 KO mice, which will provide an important reference for genetic counselling and clinical treatment of male infertility.

eLife. 2024 Nov 6;13:RP96755. doi: 10.7554/eLife.96755.4.sa4

Author response

Xiang Wang 1, Gan Shen 2, Yihong Yang 3, Chuan Jiang 4, Tiechao Ruan 5, Xue Yang 6, Liangchai Zhuo 7, Yingteng Zhang 8, Yangdi Ou 9, Xinya Zhao 10, Shunhua Long 11, Xiangrong Tang 12, Tingting Lin 13, Ying Shen 14

The following is the authors’ response to the previous reviews.

Public Reviews:

Reviewer #1 (Public Review):

Summary:

Wang and colleagues identify biallelic variants of DNAH3 in four unrelated Han Chinese infertile men through whole-exome sequencing, which contributes to abnormal sperm flagellar morphology and ultrastructure. To investigate the importance of DNAH3 in male infertility, the authors generated crispant Dnah3 knockout (KO) male mice. They observed that KO mice are also infertile, showing a severe reduction in sperm movement with abnormal IDA (inner dynein arms) and mitochondrion structure. Moreover, nonfunctional DNAH3 expression decreased the expression of IDA-associated proteins in the spermatozoa of patients and KO mice, which are involved in the disruption of sperm motility. Interestingly, the infertility of patients and KO mice is rescued by intracytoplasmic sperm injection (ICSI). Taken together, the authors propose that DNAH3 is a novel pathogenic gene for asthenoterozoospermia and male infertility.

Strengths:

This work investigates the role of DNAH3 in sperm mobility and male infertility. By using gold-standard molecular biology techniques, the authors demonstrate with exquisite resolution the importance of DNAH3 in sperm morphology, showing strong evidence of its role in male infertility. Overall, this is a very interesting, well-written, and appealing article. All aspects of the study design and methods are well described and appropriate to address the main question of the manuscript. The conclusions drawn are consistent with the analyses conducted and supported by the data.

Weaknesses:

The paper is solid, and in its current form, I have not detected relevant weaknesses.

We thank the comments from the reviewer very much.

Reviewer #2 (Public Review):

Wang et al. investigated the role of dynein axonemal heavy chain 3 (DNAH3) in male infertility. They found that variants of DNAH3 were present in four infertile men, and the deficiency of DNAH3 in sperm affects sperm mobility. Additionally, they showed that Dnah3 knockout male mice are infertile. Furthermore, they demonstrated that DNAH3 influences inner dynein arms by regulating several DNAH proteins. Importantly, they showed that intracytoplasmic sperm injection (ICSI) can rescue the infertility in Dnah3 knockout mice and two patients with DNAH3 variants.

Strengths:

The conclusions of this paper are well-supported by data.

Weaknesses:

The sample/patient size is small; however, the findings are consistent with those of a recent study on DNAH3 in male infertility involving 432 patients.

We extend our sincere gratitude to the expert reviewers for their valuable comments and insightful suggestions.

A cohort of 587 unrelated infertile men with asthenoteratozoospermia was recruited to investigate the potential genetic etiology using WES. In addition to mutations in DNAH3 identified in four patients, mutations in serval other genes previous reported by our group, including CFAP65 (Zhang et al., 2019. PMID: 31571197), (Yang et al., 2020. PMID: 32681648), (Li et al., 2022. PMID: 34791246), (Zheng et al., 2023. PMID: 35654582), (Zhang et al., 2022. PMID: 35296684), (Zhang et al., 2022. PMID: 36206347), (Zhang et al., 2023. PMID: 36481789), (Wang et al., 2023. PMID: 36415156), (Zhang et al., 2024. PMID: 38228861), (Jin et al., 2023. PMID: 38126872), (Ruan et al., 2023. PMID: 36967801), (Liu et al., 2022. PMID: 35821214), as well as other unreported variants were also identified.

Reviewer #3 (Public Review):

Summary:

(1) To further explore the genetic basis of asthenoteratozoospermia, the authors performed whole-exome sequencing analyses among infertile males affected by asthenoteratozoospermia. Four unrelated Han Chinese patients were found to carry biallelic variations of DNAH3, a gene encoding IDA-associated protein.

(2) To verify the function of IDA associated protein DNAH3, the authors generated a Dnah3-KO mouse model and revealed that the loss of DNAH3 leads to severe male infertility as a result of the severe reduction in sperm movement with the abnormal IDA and mitochondrion structures.

(3) Mechanically, they confirmed decreased expression of IDA-associated proteins (including DNAH1, DNAH6 and DNALI1) in the spermatozoa from patients with DNAH3 mutations and Dnah3-KO male mice.

(4) Then, they also found that male infertility caused by DNAH3 deficiency could be rescued by intracytoplasmic sperm injection (ICSI) treatment in humans and mice.

Strengths:

(1) In addition to existing research, the authors provided novel variants of DNAH3 as important factors leading to asthenoteratozoospermia. This further expands the spectrum of pathogenic variants in asthenoteratozoospermia.

(2) By mechanistic studies, they found that DNAH3 deficiency led to decreased expression of IDA-associated proteins, which may be used to explain the disruption of sperm motility and reduced fertility caused by DNAH3 deficiency.

(3) Then, successful ICSI outcomes were observed in patients with DNAH3 mutations and Dnah3 KO mice, which will provide an important reference for genetic counselling and clinical treatment of male infertility.

We are very grateful for the reviewer's careful comments.

Recommendations for the authors:

Reviewer #1 (Recommendations for The Authors):

I have carefully read the revised versions of this manuscript, and I would like to thank the authors for addressing all my previous concerns.

I have no additional comments or suggestions.

We thank the reviewer for reviewing our revised manuscript.

Reviewer #2 (Recommendations for The Authors):

(1) Statistical analyses should be provided alongside the quantification (Fig S1B, S7C).

According to the suggestions of the reviewer, we have added statistical analyses of the corresponding quantification in the legends of Figure S1 and Figure S7.

(2) The numbers of sperms counted in Fig S1A should be listed.

In response to reviewer's valuable suggestions. We have listed the corresponding ratio of different morphological defects in sperm tail of the patients in Figure S1A.

(3) Due to the high similarities in experimental design, data and conclusions between the current study and previously published work by Meng et al. (2024), as well as the very similar titles of the two studies, it is crucial to emphasize the differences in the Discussion section.

Many thanks for reviewer's kind suggestions for our revised manuscript.

Employing whole-exome sequencing (WES) on infertile men to identify candidate variants, followed by in-silico and functional analysis of these variants, and generating mouse models using CRISPR-Cas9 technology, has proven to be an efficient and widely used approach for uncovering the causative genes of male infertility associated with sperm defects. Both our study and the recent work by Meng et al. utilized this approach to verify whether DNAH3 mutations are a cause of asthenoteratozoospermia. Additionally, we have also updated the title of our study to: 'DNAH3 deficiency causes flagellar inner dynein arm loss and male infertility in humans and mice'.

Meng et al. reported DNAH3 mutations in asthenoteratozoospermia affected patients, revealing multiple morphological defects in sperm tail. Moreover, ultrastructural abnormalities of the flagellar axoneme in the patients were evident in these patients, characterized by a disrupted '9+2' arrangement and the notable absence of IDAs. Additionally, they generated Dnah3 KO mice, which were infertile and exhibited moderate morphological abnormalities. While the '9+2' microtubule arrangement in the flagella of their Dnah3 KO mice remained intact, the IDAs on the microtubules were partially absent. In our study, we observed similar phenotypic differences between DNAH3-deficient patients and Dnah3 KO mice. Both studies suggest that DNAH3 plays a crucial role in human and mouse male reproduction.

However, there are notable differences between the two studies. Firstly, the phenotypes of Dnah3 KO mice showed slight differences. Meng et al. generated two Dnah3 KO mouse models (KO1 and KO2), and both of which exhibited significantly higher sperm motility and progressive motility than in our study, where nearly all sperm were completely immobile. Furthermore, their Dnah3 KO2 mice even displayed motility comparable to WT mice and retained partial fertility. We speculate that these differences may be attributed to variations in mouse genetic background or the presence of a truncated DNAH3 protein resulting from specific knockout strategies. Secondly, we conducted additional research and uncovered novel findings. We revealed that male infertility caused by DNAH3 mutations follows an autosomal recessive inheritance pattern, as confirmed through Sanger sequencing of the patients' parents. We also discovered the dynamic expression and localization of DNAH3 during spermatogenesis in humans and mice through immunofluorescent staining. We further found that DNAH3 deficiency had no impact on ciliary development in the oviduct or on oogenesis in mice, resulting in normal female fertility. Moreover, in the absence of DNAH3 in both humans and mice, the expression of IDA-associated proteins, including DNAH1, DNAH6 and DNALI1, was decreased, while the expression of ODA-associated proteins remained unaffected, indicating that DNAH3 is involved in sperm axonemal development, specifically through its role in the assembly of IDAs. Collectively, our study corroborates the findings of Meng et al., and provides additional unique insights, comprehensively elucidating the critical role of DNAH3 in human and mouse spermatogenesis.

We have added these discussions in line 275 to line 306.

Reviewer #3 (Recommendations for The Authors):

I have no more recommendations for the authors.

We thank the reviewer for reviewing our revised manuscript.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Wang X, Shen G, Yang Y, Jiang C, Ruan T, Yang X, Zhuo L, Zhang Y, Ou Y, Zhao X, Long S, Tang X, Lin T, Shen Y. 2024. DNAH3 deficiency causes flagellar inner dynein arm loss and male infertility in humans and mice. NGDC Genome Sequence Archive for Human. HRA007467 [DOI] [PMC free article] [PubMed]

    Supplementary Materials

    Figure 1—source data 1. Summary of whole exome sequencing and the candidate variants identified.
    Figure 1—source data 2. Primers for Sanger sequencing.
    Figure 1—source data 3. PDF file containing original western blotting for Figure 1D.
    Figure 1—source data 4. Original files for western blotting analysis displayed in Figure 1D.
    Figure 2—figure supplement 1—source data 1. The percentage distribution of various flagellar morphology in the normal control and patients.
    Figure 4—figure supplement 1—source data 1. PDF file containing original gels for Figure 4—figure supplement 1A, B.
    Figure 4—figure supplement 1—source data 2. Original files for gel analysis displayed in Figure 4—figure supplement 1A, B.
    Figure 4—figure supplement 3—source data 1. Primers for Sanger sequencing and qPCR.
    Figure 5—source data 1. PDF file containing original western blotting for Figure 5D–F and Figure 6D–F.
    Figure 5—source data 2. Original files for western blotting analysis displayed in Figure 5D–F and Figure 6D–F.
    MDAR checklist

    Data Availability Statement

    The published article includes all datasets generated or analyzed during this study. The whole exome-sequencing data were deposited in the National Genomics Data Center (NGDC) (https://ngdc.cncb.ac.cn/, accession number: HRA007467).

    The following dataset was generated:

    Wang X, Shen G, Yang Y, Jiang C, Ruan T, Yang X, Zhuo L, Zhang Y, Ou Y, Zhao X, Long S, Tang X, Lin T, Shen Y. 2024. DNAH3 deficiency causes flagellar inner dynein arm loss and male infertility in humans and mice. NGDC Genome Sequence Archive for Human. HRA007467


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES